Recognition List Number: 028 Publication Date: 03/16/2012
Part B: SUPPLEMENTARY INFORMATION
Recognition Number 3-100: AAMI / ANSI / IEC 60601-2-27:2011, Medical electrical equipment - Part 2-27: Particular requirements for the basic safety and essential performance of electrocardiographic monitoring equipment. (Cardiovascular)
Date of Standard: 2011. |
| Addresses of Standards Organizations: |
| Association for the Advancement of Medical Instrumentation (AAMI) |
| 4301 North Fairfax Drive |
| Suite 301 |
| Arlington, VA 22203 |
| |
| American National Standards Institute (ANSI) |
| 25 West 43rd Street |
| 4th Floor |
| New York, NY 10036 |
| |
| International Electrotechnical Commission (IEC) |
| 3, Rue de Varembe' |
| PO Box 131 |
| CH-1211 Geneva 20, 0 |
|
SWITZERLAND
|
|
| CDRH Office and Division Associated with Recognized Standards: |
| OFFICE OF DEVICE EVALUATION (ODE) | | DIVISION OF CARDIOVASCULAR DEVICES (DCD) |
|
|
| Devices Affected: |
| Electrocardiographic monitors |
|
| Processes Affected: |
|
| Type of Standard: |
| Vertical, International |
| Extent of Recognition: |
The complete standard is recognized except for any reference to IEC 60601-1:2005 (i.e. the 3rd edition of 60601-1). FDA recognizes the ANSI/AAMI ES60601-1:2005 standard instead.
FDA recognition of IEC 60601-2-27: 2005-08, is hereby superseded by recognition of ANSI/AAMI/IEC 60601-2-27:2011 Medical electrical equipment ? Part 2-27: 2011 Medical electrical equipment ? Part 2-27: Particular requirements for the basic safety and essential performance of electrocardiographic monitoring equipment. FDA will accept declarations of conformity, in support of premarket submissions, to IEC 60601-2-27: 2005-08 until June 30, 2013. After this transitional period, declarations of conformity to IEC 60601-2-27 2005-08 will not be accepted. |
|
| Related CFR Citations and Product Codes: |
Regulation Number |
Device Name |
Device Class |
Product Code |
| §870.2340 |
Electrocardiograph |
Class 2 |
DPS |
| |
|
| Relevant Guidance: |
| There is no relevant guidance developed at this time. |
|
| FDA Technical Contact: |
| Charles Ho, Ph.D. |
| FDA/CDRH/ODE |
| 10903 New Hampshire Avenue Building 66, Room 1318 |
| Silver Spring MD 20993 |
| 301/796-6320 |
| Email: charles.ho@fda.hhs.gov |
|
|